Promega SARS-CoV-2 antibody test gets CE Mark

By staff writers

Promega's SARS-CoV-2 antibody test, Lumit Dx SARS-CoV-2 Immunoassay, has received the CE Mark and is now available in Europe. The test is based on bioluminescence, which Promega believes offers workflow advantages.

The assay is a qualitative IVD test that detects antibodies against the receptor-binding domain antigen within the SARS-CoV-2 spike in serum in less than one hour at room temperature.

Additionally, the bioluminescent test offers a simple add-incubate-read workflow and requires no wash steps.

Copyright © 2021

To read this and get access to all of the exclusive content on, create a free account or sign in now.

Member Sign In:
MemberID or email address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?